Show simple item record

dc.contributor.authorAmornkul, P.N
dc.contributor.authorVandenhoudt, H
dc.contributor.authorOdhiambo, F,
dc.contributor.authorMwaengo, D
dc.contributor.authorJuma, B
dc.contributor.authorOuma, J,
dc.contributor.authorNasokho, P
dc.contributor.authorRosen, D
dc.contributor.authorVulule, J
dc.contributor.authorVitek, C
dc.contributor.authorMisore, A
dc.contributor.authorGreenberg, A
dc.contributor.authorSlutsker, L
dc.contributor.authorDe Cock, K.M
dc.date.accessioned2013-04-25T06:03:55Z
dc.date.available2013-04-25T06:03:55Z
dc.date.issued2009
dc.identifier.citationPLoS One. 2009 Jul 31;4(7):e6470en
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/16643
dc.description.abstractTo estimate HIV prevalence and characterize risk factors among young adults in Asembo, rural western Kenya. Community-based cross-sectional survey. From a demographic surveillance system, we selected a random sample of residents aged 13-34 years, who were contacted at home and invited to a nearby mobile study site. Consent procedures for non-emancipated minors required assent and parental consent. From October 2003 - April 2004, consenting participants were interviewed on risk behavior and tested for HIV and HSV-2. HIV voluntary counseling and testing was offered. Of 2606 eligible residents, 1822 (70%) enrolled. Primary reasons for refusal included not wanting blood taken, not wanting to learn HIV status, and partner/parental objection. Females comprised 53% of 1762 participants providing blood. Adjusted HIV prevalence was 15.4% overall: 20.5% among females and 10.2% among males. HIV prevalence was highest in women aged 25-29 years (36.5%) and men aged 30-34 years (41.1%). HSV-2 prevalence was 40.0% overall: 53% among females, 25.8% among males. In multivariate models stratified by gender and marital status, HIV infection was strongly associated with age, higher number of sex partners, widowhood, and HSV-2 seropositivity. Asembo has extremely high HIV and HSV-2 prevalence, and probable high incidence, among young adults. Further research on circumstances around HIV acquisition in young women and novel prevention strategies (vaccines, microbicides, pre-exposure prophylaxis, HSV-2 prevention, etc.) are urgently needed.en
dc.language.isoenen
dc.titleHIV prevalence and associated risk factors among individuals aged 13-34 years in rural westernen
dc.typeArticleen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record